You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (200)

Journals (0)

1-10 of 200 results for FDA Adverse Event Reporting System

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Vonoprazan-associated Clostridioides difficile infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System

Open access

Research article

First published 2024

Vonoprazan-associated Clostridioides difficile infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System

Mengling Ouyang, Shupeng Zou, Qian Cheng [...]

Therapeutic Advances in Drug Safety

Select article: Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System

Open access

Brief report

First published 2025

Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System

Afsaneh Shirani, Samuel A. Goldlust, Olaf Stuve

Therapeutic Advances in Neurological Disorders

Select article: Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System

Retricted access

Research article

First published 2019-10

Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System

Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi [...]

Multiple Sclerosis Journal

Select article: Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database

Open access

Research article

First published 2025-10

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database

Weixing Zhao, Xiaoni Jin, Yuan Li [...]

Science Progress

Select article: Adverse events associated with lecanemab: A disproportionality analysis of data from the FDA adverse event reporting system

Retricted access

Research article

First published 2025-6

Adverse events associated with lecanemab: A disproportionality analysis of data from the FDA adverse event reporting system

Jiahao Li, Feng Zhang, Ulrich LM Eisel

Journal of Alzheimer’s Disease

Select article: Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System

Open access

Research article

First published 2024

Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System

Huqun Li, Cuilian Guo, Chongshu Wang

Therapeutic Advances in Drug Safety

Select article: Descriptive analysis of anaphylactic events reported in the FDA Adverse Event Reporting System (FAERS)

Open access

Research article

First published 2026-1

Descriptive analysis of anaphylactic events reported in the FDA Adverse Event Reporting System (FAERS)

Nehad Jaser Ahmed

Journal of Public Health Research

Select article: Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data

Retricted access

Research article

First published 2025-2

Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data

Wukun Ge, Yingyan Yan, Yaoyao Hu [...]

Journal of Alzheimer’s Disease

Select article: Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database

Retricted access

Research article

First published 2021-11

Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database

Hyunwoo Kim, Colin M Pfeiffer, Matthew P Gray [...]

Respiratory Care

Select article: Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System

Open access

Research article

First published 2025

Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System

Haiyan Mai, Zhenpo Zhang, Yankun Liang [...]

Therapeutic Advances in Drug Safety

1
2
3
•••
20
10 / page

Article type

Publication date

Subjects

Access